Di­ver­si­ty of Hu­mi­ra biosim­i­lar launch­es re­veals the dif­fi­cul­ty of de­thron­ing Ab­b­Vie's megablock­buster

San­doz, Boehringer In­gel­heim, Organon/Sam­sung and oth­ers are now tak­ing their shot at Ab­b­Vie’s megablock­buster Hu­mi­ra, with launch­es of their biosim­i­lars on Sat­ur­day, and myr­i­ad ap­proach­es …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER